Navigation Links
The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana-Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection
Date:9/3/2009

of future treatments against infectious diseases."

According to Professor Didier Trono, Dean of the Life Sciences Faculty at the EPFL, "Following the momentum created by the sequencing of the human genome and capitalising on new technologies of high throughput DNA analysis, the studies conducted by Dr Lluis Quintana-Murci teach us about the history of humanity and its struggles against pathogens. They suggest new therapeutic avenues for the control of infectious diseases."

"Receiving the Debiopharm Life Sciences Award encourages us to go further in our research on the correlation between genetic variation in human genes and our chances to develop an infectious disease. This information is critical to a more precise development of vaccines and therapeutics concerning these microbial sensors. Most importantly, this prize honours the field of human evolutionary genetics by recognising it as an indispensable complement to the clinical and epidemiological genetics of infection," added Dr Quintana-Murci.

About the Debiopharm Life Sciences Award

The Award was set up in 2006 to mentor and motivate young innovative European researchers in the field of life sciences. Criteria for applications include novelty and originality of the work, as well as its importance and significance in connection with targeted therapeutic fields.

About Debiopharm Group

Debiopharm Group is a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. The group in-licenses promising biological and small molecule drug candidates. It develops its products for global registration and maximum commercial potential. Once registered, the products are out-licensed to pharmaceutical partners for sales and marketing.

Debiopharm independently funds the worldwide development of all of its products while provid
'/>"/>

SOURCE Debiopharm Group
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305
2. Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic
3. Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours
4. Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions
5. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
6. Japanese Cancer Association and Debiopharm Honour Japanese Research
7. Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
8. Debiopharm and EPFL Establish an Oncology Chair
9. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
10. Debiopharm Receives cGMP Certification for Quality Control of its Drug Products
11. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...NSING,Mich.,Nov.23/PRNewswire-FirstCall/--NeogenCo....Crowder,Ph.D.,waselectedtoNeogen,sBoardofDirector...,, Crowderhasmorethan40yearsofexperienceinthefo...sasanadjunctprofessorofagriculturaleconomicsatVirg...ervedasUnitedStateschiefagriculturenegotiatorwitht...
(Date:11/23/2009)...DWOODCITY,Calif.,Nov.23/PRNewswire/--PearlTherapeu...euticproductsforthetreatmentofchronicrespiratorydi...hecompany,sBoardofDirectors.Mr.Rosenhas25yearsofex...ies,includingkeyrolesatGileadSciencesandALZACorpor...nPearl,sBoardtosix. ,, "Howiebringsawealthofpro...
(Date:11/20/2009)..., SEATTLE, Nov. 20 Dendr...hat the U.S. Food and Drug Administration (FDA) pr...amended Biologics License Application (BLA) for PR.... The FDA has assigned a Prescription Drug User F...it will respond to Dendreon,s amended BLA. Dendre...
(Date:11/20/2009)... METTLER TOLEDO recently announced ...binar, “The Role of Process Analytical Techn...ng” on December 1, 2009. , ...he Role of Process Analytical Technology (PAT) in ...December 1, Process Analytical Technology (PAT) ca...
Breaking Biology Technology:Richard T. Crowder Joins Neogen's Board of Directors 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2
...g to thrive in an increasingly competitive atmosph...sconsin Public Radio reports on one rather unusual...d-dating introduced in by The Wisconsin Technology...ayer , ,Its not the big that eat the small; its t... kick off a business seminar on speed networking, ...
...r Midwestern technology job seekers. Its also for ...ntrated so hard on job seekers here? Because so ma...the reason. More than that, it,s because theres so...gy job hunting. So many things to know. So many an...o many ways to scotch your chances for your next g...
...tities approved by the federal Food and Drug Admin...crambling for ways to speed up the laborious drug ...8 years from the start of target discoveryidentify...to influenceto introduce a new drug to market. The...cal companies and the research firms that contract...
Other Biology Technology:Looking to be Competitive? Try Speed Networking 2Its Your Midwest Technology Wake, Stupid 2Its Your Midwest Technology Wake, Stupid 3Researchers Push for Faster Drug Development 2Researchers Push for Faster Drug Development 3
(Date:11/23/2009)... of the Interuniversity Professorship in Law and t...ersity of the Basque Country. The Professorship is...erts such as researchers in the fields of molecula.... , The Interuniversity Professorship in Law and...nd the Basque Country was created in 1993. The wor...
(Date:11/23/2009).... , Not just birds, but also a few species o... at Princeton University in the U.S. and at the Ma...Germany studied the migratory behaviour of the lar...ilionidae" with the help of mathematical models. T...ll as long distances of various kinds of bats evol...
(Date:11/22/2009)...ntists have succeeded in producing the polymers us...ather than through the use of fossil fuel based ch...ow allow for the production of environmentally con... journal Biotechnology and Bioengineering to mar...e molecules found in everyday life in the form of ...
Breaking Biology News(10 mins):Research and legislation should go hand in hand, as much as possible 2We're off then: The evolution of bat migration 2Bioengineers succeed in producing plastic without the use of fossil fuels 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 1Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10426 17Clues to Hypertension in Kids May Be Seen in Bones 59798 1Clues to Hypertension in Kids May Be Seen in Bones 59798 2Leg Clots May Not Travel to Lungs 59796 1Leg Clots May Not Travel to Lungs 59796 2Leg Clots May Not Travel to Lungs 59796 3
...at the body,s normally protective inflammation res...e fully malignant, UCSF scientists report discover... process. , Typically, the "innate" immune system...engulf and destroy invading microbes when receptor...the blood -- often an antibody produced by a B cel...
...to gene therapy involves short DNA fragments (inte... their "translation" into the corresponding, disea... efficient and targeted delivery of RNA into the c...niversity have chosen to use carbon nanotubes as t...m to successfully introduce RNA fragments that "sw...
...ase sequence in duplex nucleic acid has long been ...ublish "Heteropolymeric Triplex-Based Genomic Assa...rphisms in Human Genomic Samples" in the March 21s...access, online journal, PLoS ONE. , In the articl...say of pathogens in samples also containing human ...
Other Biology News:Antibody signal may redirect inflammation to fuel cancer 2Antibody signal may redirect inflammation to fuel cancer 3Batten down the hatches against HIV 2Triplex assay used to assay duplex genomic DNA 2
Baker's yeast (S. cerevisiae) S-Acetyl-coenzyme A synthetase from Sigma-Aldrich
...isplay Vector is specifically designed to target a...Saccharomyces cerevisiae. Displayed proteins can b...n or putative ligands. pYD1 uses the a-agglutinin ...ins Aga1 and Aga2 to display recombinant protein o...
...r of a class of proteins who function to ensure th...tegral role in proofreading the nascent strands in...tide excision repair and in preventing chromosomal...ia. Mut S binds to DNA specifically at base pair m...
15(S)-HEDE from Cayman Chemical
Biology Products: